Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer
Clinical trial NCT02342587 · COMPLETED
Trial details
- NCT number
- NCT02342587
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-03
- Primary completion
- 2016-01-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.